India's pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

RA: What do you think the implications would be of restrictions to the FDI policy in pharma? TR: India witnessed the second highest growth ... industry, in the globalized economy. 2) Need for ...

As India’s pharmaceutical and healthcare industries ... An increase in healthcare spending to 2.5-3% of GDP is necessary for sustained industry growth. With a strategic policy push, India is ...

increased demand for pharmaceutical products and a revival in export activities. Sheetal Sapale, vice-president (commercial), Pharmarack, said, "The growth is pretty much in line with the India ...

the industry now looks forward to policies that further align with India’s ambition of becoming a $130B pharma market by 2030. “This year’s expectations revolve around incentivising research ...

The industry leaders of the Indian healthcare and pharma sector sharing the wishlist for the upcoming Union Budget 2024- 2025, urge the union government to increase healthcare spending to 2.5 per ...

With pharmaceutical companies heavily investing in R&D and precision medicine, the demand for high-quality specialty APIs is ...

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...